Thursday, 24 April 2008

Drug Approvals

*Akorn-Strides announced the approvals of two ANDAs for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials


*Taro Pharma reported today that it has received final approval from the USFDA for its ANDA for cetirizine hydrochloride oral solution, 1 mg / 1 ml

*Mylan announced that it has received final approval from the USFDA for its ANDA for Felodipine Extended-release Tablets USP, 2.5 mg, 5 mg and 10 mg.

Posted by ADKS at 5:45 pm

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker